Medications

Simponi Aria (golimumab) Approved by the FDA for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older

HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This […]

Health News

Men and younger adults less active in lockdown

New research published in the journal BMJ Open Sport and Exercise Medicine indicates that men and younger adults have been less physically active during the COVID-19 lockdown. The study, led by Anglia Ruskin University (ARU) and Ulster University, includes data from 911 UK adults who took part in an online survey which began on 17 […]